Barclays Cuts PT on Blackstone Inc. (BX) to $126 From $164 - Here's Why

Blackstone Inc. (NYSE:BX) is one of the best undervalued stocks to invest in right now.

Barclays cut the price target on Blackstone Inc. (NYSE:BX) to $126 from $164 on March 2, maintaining an Equal Weight rating on the shares while revising estimates across the alternative asset manager group. The firm told investors that while it is too early to determine the real AI impact on portfolio companies, it lowered business development company-related earnings on lower flow assumptions and realization.

In another development, Blackstone Inc. (NYSE:BX) reported on February 23 that Blackstone Life Sciences (BXLS) announced a research and development funding agreement to advance the clinical development of bleximenib, which is an investigational oral menin inhibitor, for acute myeloid leukemia (AML). Management stated that despite AML being the most common type of acute leukemia in adults, it continues to be an extremely challenging ailment to treat and has the lowest survival of all leukemia types.

Blackstone Inc. (NYSE:BX) further reported that Johnson & Johnson and funds managed by BXLS would jointly finance a portion of the ongoing and future clinical trials of bleximenib in AML. The agreement marks the first time that BXLS and Johnson & Johnson have entered into a co-funding agreement.

Blackstone Inc. (NYSE:BX) provides investment and fund management services. The company operates through the following segments: Real Estate, Private Equity, Credit and Insurance, and Hedge Fund Solutions.

While we acknowledge the potential of BX as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money.

Disclosure: None. Follow Insider Monkey on Google News.